Boston Scientific Adjusts FY19 Outlook, Issues Weak Q2 Guidance - Quick Facts

While reporting financial results for the first quarter, Boston Scientific Corp. (BSX) on Wednesday adjusted its earnings and revenue growth guidance for the full-year 2019 and also provided outlook for the second quarter below estimates.

from RTT - Earnings http://bit.ly/2IFbl7k
via IFTTT